A guest blog by David C. Norris, who together with Andrew Wilson recently published ‘Early-childhood housing mobility and subsequent PTSD in adolescence: a Moving to Opportunity reanalysis’ in our Preclinical Reproducibility and Robustness channel. In the 1990s, Congress mandated the ‘Moving To Opportunity for Fair Housing Demonstration’ (MTO)—a randomized, controlled social experiment. MTO…
It has been half a year since the Preclinical Reproducibility & Robustness (PRR) channel was launched. PRR provides a venue for researchers to publish both confirmatory and non-confirmatory studies to help improve reproducibility of results, mitigate publication bias towards positive results and to promote open dialogue between scientists. A number of invaluable replication attempts have…
Guest post by Alex Holcombe, Nicholas Brown, Patrick Goodbourn, Alexander Etz and Sebastian Geukes
In recent months, there has been a lot of discussion in the biology research community about the potential of preprints as a tool to accelerate the dissemination of scientific results and ideas. Preprints in biology While preprints are well-established in other fields of science (particularly physics, mathematics and computer science through arXiv), they are still a…
In response to rising concerns about irreproducible science and the lack of somewhere to openly discuss these issues, we recently launched the Preclinical Reproducibility and Robustness Channel. Our aim is to provide a place to publish confirming and non-confirming studies with the full methodologies and underlying data being made available. We want the channel to…
Today, we are very excited to unveil the Preclinical Reproducibility and Robustness channel, a new dedicated venue for life scientists to publish and discuss confirmatory and non-confirmatory research results. We are also delighted to have this new channel championed by former Editor-in-Chief of Science magazine and F1000 International Advisory Board member, Bruce Alberts and Amgen’s…
In December, Dr Vikash Bhardwaj from Lovely Professional University in India published an article in F1000Research that showed that he was able to generate PCR products in a parallel (rather than antiparallel) direction. In this blog post he describes some of the opportunities and conversations that followed this publication, and introduces his opinion piece “Villain…
Recently, Cesar Berrios hosted a very successful tweetchat about diversity among researchers. You can read the summary of that discussion here. Tomorrow we’re hosting another #F1000Talks tweetchat. This time, I will be running the @F1000Research Twitter account to talk about reproducibility in research. Reproducibility is an ongoing concern in the life sciences. Experimental results are…
